Location

: Barcelona - Spain (3 days working from the office and 2 days working from home) At

Alexion, AstraZeneca Rare Disease

, this role offers the opportunity to shape access for transformative medicines in areas of high unmet need and make a meaningful impact for patients living with

rare neurological diseases

. You will operate in a highly visible, strategic position with broad cross-functional exposure, leading portfolio-level market access, pricing, and reimbursement strategy across key markets, with a particular focus on the

NMOSD

indication. This is an opportunity for an experienced market access leader to influence critical launch and lifecycle decisions, navigate complex payer environments, and play a central role in advancing our ambition within

Neurology

. What you’ll will do:

Join a highly valued, strategic team that is fundamental to realizing the potential of our life-changing medicines. Through our work, AstraZenecais able toensure that appropriate access is provided to our transformative therapies. Alexion, AstraZeneca Rare Disease’s

General Value Access and Pricing (

GVAP

) team is seeking a qualified

Director

to join a dynamic and growing team, with responsibility for

Neurology

indications, including near-term new product launches and label expansions. As a key member of the

GVAP

team, you will help shape and execute global value, access, and pricing strategies across the

Neurology portfolio

in selected key EU markets

, with particular strategicfocus on the

NMOSD indication





and its lifecycle management This is a strategic role that leverages your understanding and application of global healthcare and health technology assessment (

HTA

) systems, competitive insights, and clinical knowledge to shape market access, pricing, and reimbursement success for critical product launches and indications. The ideal candidate for this role will have deep expertise in global payer,

HTA

, and reimbursement ecosystems, with a strong track record of driving market access, pricing, and reimbursement success within

rare diseases and Neurology

. You will be responsible for:

Value

Lead and drive cross-functional development of a clear, differentiated value proposition for

NMOSD

, while influencing without authority and navigating complex organizational systems. Collaborate with cross-functional teams to ensure that evidence generation plans and real-world evidence (

RWE

) are incorporated effectively to deliver a comprehensive value proposition, reduce uncertainty for payers, and optimize patient access. This includes securing timely country input on endpoints and evidence generation plans in priority target countries. Provide support to the

GMMA Commercial

team to advance

NMOSD lifecycle management (LCM)

through governance milestones focused on market access potential, evidence, and

target product profile (TPP)

requirements. Access





Leaddevelopmentofglobal market access and pricing strategies-activitiesandsupport implementationin close partnership with country access representativesofassigned countries Lead the assessment of pricing and reimbursement (

P&R;

) risks and opportunities, and the implementation of corresponding mitigation actions specific to

Neurology

. Create and roll out strategic value, access, and pricing communication tools and materials for

NMOSD

to support local

P&R;

submissions and negotiations, such as pricing frameworks, negotiation strategies, and toolkits, in alignment with the enterprise-wide launch framework. Lead the update of the global reimbursement dossier for

NMOSD

and the overall cross-functional market access readiness plans for

Neurology

, in close collaboration with key countries and support functions (

HEOR, Medical, and Commercial

). Represent the

GVAP

perspective and strategy across various cross-functional teams, including the

Global Value Sub-Team

and

Global Launch Team

, and provide updates and guidance to local teams as needed. Own the monthlyNeurologypayer working group to share the latest evidence and drive best practice sharing across countries. Understand and incorporate thepatientperspective on thedisease, andrecommend strategies that support thepatientvoice in key payer negotiations. Pricing

Support the development ofthe

Neurology

pricing strategy. Conduct payer and value assessments to identify key market-specific P&R; drivers and barriers, develop differentiated value proposition

📌 Global Pricing (Barcelona)
🏢 Alexion Pharmaceuticals Inc
📍 Barcelona